AU4949901A - Methods for inhibiting angiogenesis and tumor growth - Google Patents

Methods for inhibiting angiogenesis and tumor growth

Info

Publication number
AU4949901A
AU4949901A AU4949901A AU4949901A AU4949901A AU 4949901 A AU4949901 A AU 4949901A AU 4949901 A AU4949901 A AU 4949901A AU 4949901 A AU4949901 A AU 4949901A AU 4949901 A AU4949901 A AU 4949901A
Authority
AU
Australia
Prior art keywords
methods
tumor growth
inhibiting angiogenesis
angiogenesis
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU4949901A
Inventor
Dale L Boger
David A Cheresh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU4949901A publication Critical patent/AU4949901A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
AU4949901A 2000-03-27 2001-03-27 Methods for inhibiting angiogenesis and tumor growth Pending AU4949901A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19226000P 2000-03-27 2000-03-27
PCT/US2001/009785 WO2001072297A1 (en) 2000-03-27 2001-03-27 Methods for inhibiting angiogenesis and tumor growth

Publications (1)

Publication Number Publication Date
AU4949901A true AU4949901A (en) 2001-10-08

Family

ID=22708924

Family Applications (4)

Application Number Title Priority Date Filing Date
AU2001249499A Ceased AU2001249499B2 (en) 2000-03-27 2001-03-27 Methods for inhibiting angiogenesis and tumor growth
AU2001251018A Ceased AU2001251018B2 (en) 2000-03-27 2001-03-27 Inhibition of angiogenesis and tumor growth
AU5101801A Pending AU5101801A (en) 2000-03-27 2001-03-27 Inhibition of angiogenesis and tumor growth
AU4949901A Pending AU4949901A (en) 2000-03-27 2001-03-27 Methods for inhibiting angiogenesis and tumor growth

Family Applications Before (3)

Application Number Title Priority Date Filing Date
AU2001249499A Ceased AU2001249499B2 (en) 2000-03-27 2001-03-27 Methods for inhibiting angiogenesis and tumor growth
AU2001251018A Ceased AU2001251018B2 (en) 2000-03-27 2001-03-27 Inhibition of angiogenesis and tumor growth
AU5101801A Pending AU5101801A (en) 2000-03-27 2001-03-27 Inhibition of angiogenesis and tumor growth

Country Status (15)

Country Link
EP (2) EP1276713A4 (en)
JP (2) JP2003528850A (en)
KR (2) KR100776185B1 (en)
CN (2) CN1245967C (en)
AU (4) AU2001249499B2 (en)
CA (3) CA2403871C (en)
CZ (2) CZ20023510A3 (en)
HU (2) HUP0301797A3 (en)
MX (2) MXPA02009510A (en)
NO (2) NO328969B1 (en)
PL (2) PL358272A1 (en)
RU (2) RU2269339C2 (en)
SK (2) SK14842002A3 (en)
WO (2) WO2001072297A1 (en)
ZA (2) ZA200208628B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4836797B2 (en) 2003-10-23 2011-12-14 大塚製薬株式会社 Controlled release sterile injection aripiprazole formulations and methods
AR067747A1 (en) 2007-07-31 2009-10-21 Otsuka Pharma Co Ltd METHODS TO PRODUCE SUSPENSION OF ARIPIPRAZOL AND LIOFILIZED FORMULATION

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
JPH05125029A (en) * 1991-11-06 1993-05-21 Yamanouchi Pharmaceut Co Ltd New amide compound or its salt
GB9308695D0 (en) * 1993-04-27 1993-06-09 Celltech Ltd Peptidyl derivatives
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
KR20000068415A (en) * 1996-09-04 2000-11-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 Compounds for and a Method of Inhibiting Matrix Metalloproteinase
JP2001512441A (en) * 1997-02-07 2001-08-21 ザ スクリップス リサーチ インスティテュート Convergent synthesis of combinatorial libraries
CN1191063C (en) * 1998-03-27 2005-03-02 基因技术股份有限公司 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders

Also Published As

Publication number Publication date
CA2403871A1 (en) 2001-10-04
KR20020084258A (en) 2002-11-04
CN1245967C (en) 2006-03-22
HUP0301621A2 (en) 2003-09-29
EP1272173A1 (en) 2003-01-08
CA2659030A1 (en) 2001-10-04
CN1429106A (en) 2003-07-09
RU2276133C2 (en) 2006-05-10
MXPA02009510A (en) 2003-05-21
NO328969B1 (en) 2010-06-28
JP2003528140A (en) 2003-09-24
WO2001072699A1 (en) 2001-10-04
MXPA02009504A (en) 2003-05-21
CA2403630A1 (en) 2001-10-04
ZA200208626B (en) 2004-02-16
HUP0301797A2 (en) 2003-09-29
EP1272173A4 (en) 2006-05-03
WO2001072297A1 (en) 2001-10-04
NO20024576D0 (en) 2002-09-24
KR20020091156A (en) 2002-12-05
NO20024578L (en) 2002-11-20
AU2001251018B2 (en) 2005-12-01
CA2403871C (en) 2010-05-11
EP1276713A4 (en) 2006-05-03
EP1276713A1 (en) 2003-01-22
KR100767616B1 (en) 2007-10-18
AU5101801A (en) 2001-10-08
CZ20023510A3 (en) 2003-03-12
NO20024578D0 (en) 2002-09-24
CN1229339C (en) 2005-11-30
PL358272A1 (en) 2004-08-09
HUP0301621A3 (en) 2009-06-29
KR100776185B1 (en) 2007-11-16
PL205134B1 (en) 2010-03-31
ZA200208628B (en) 2004-02-12
HUP0301797A3 (en) 2010-09-28
PL366316A1 (en) 2005-01-24
AU2001249499B2 (en) 2005-04-21
JP2003528850A (en) 2003-09-30
SK14852002A3 (en) 2003-06-03
CN1441777A (en) 2003-09-10
RU2269339C2 (en) 2006-02-10
CA2403630C (en) 2009-05-26
CZ20023509A3 (en) 2003-06-18
NO20024576L (en) 2002-11-20
SK14842002A3 (en) 2003-04-01
RU2002128751A (en) 2004-03-10

Similar Documents

Publication Publication Date Title
HUP0105155A3 (en) Methods for inhibiting brain tumor growth
EP1223932A4 (en) Compounds and methods
EP1146790A4 (en) Compounds and methods
EP1605961A4 (en) Polypeptide compounds for inhibiting angiogenesis and tumor growth
EP1313477A4 (en) Compounds and methods
EP1274424A4 (en) Compounds and methods
EP1333853A4 (en) Growth factor complex
EP1296447A4 (en) High-frequency amplifier
EP1298793A4 (en) High-frequency amplifier
CA98770S (en) Pantiliner
EP1351573A4 (en) Methods for modulating tumor growth and metastasis
EP1347572A4 (en) High-frequency amplifier
EP1326328A4 (en) High-frequency amplifier
AU4949901A (en) Methods for inhibiting angiogenesis and tumor growth
GB0026015D0 (en) Cancer treatment
EP1343796A4 (en) Compounds and methods
GB2364078B (en) Ground treatment
AU6600400A (en) Methods and means for inhibiting angiogenesis
GB2367018B (en) Growth cutters
GB0016693D0 (en) Cough treatment
GB0118880D0 (en) Compostions and methods for controlling molluscs
GB9923117D0 (en) Insect-paper and methods for its formation and use
GB0000829D0 (en) Growth inhibitor
CA90931S (en) Pantiliner
CA87066S (en) Coffee marker